Drug corporations have run amok — abusing our patent system and leaving Americans bankrupt and sick.
As Pennsylvania state lawmakers weigh key measures to protect residents from Big Pharma’s skyrocketing drug prices, patients are calling for reform.
Read David Mitchell’s testimony covering his battle against multiple myeloma and imploring Congress to help patients.
We are encouraged by continued Congressional action to address an array of abusive tactics Big Pharma uses to block competition and keep drug prices high.
Today’s congressional briefing featured a bipartisan panel of experts who agreed that International Reference Pricing can lower drug prices in the U.S. while maintaining innovation.
Patients are turning up at statehouses to tell lawmakers just how harmful high drug prices have become — their voices are seeding a movement.
Patient testimony to call for urgent action in Augusta to lower drug prices.
Hearings, new legislation, and committee passage mark a productive week for drug pricing.
Patient testimony to call for urgent action to lower drug prices.
Patients appreciate Chairman Neal, Ranking Member Brady, and members on both sides of the aisle for working on an issue that is sending far too many Americans into debt.
Oregon state lawmakers are weighing key measures this week that would protect residents from Big Pharma’s skyrocketing drug prices.
The Maryland legislature officially voted to create a groundbreaking Prescription Drug Affordability Board, an independent body with the authority to evaluate high-cost prescription drugs and set reasonable rates.
Patients For Affordable Drugs Now launches 5-figure campaign to end Big Pharma’s monopolistic scheming.
Today’s actions must be the first step by this Congress on the path to lower drug prices, not the last.
Bills pass key policy committees as a vote on the floor looms.
First-in-Nation bill to create a Prescription Drug Affordability Board passes House of Delegates.
Patients For Affordable Drugs Now releases new video to support the Trump administration's International Pricing Index.
New data from the Centers For Medicare & Medicaid Services emphasized the need for Congress to pass the CREATES Act, a bipartisan bill that would lower drug prices and save taxpayers billions.